Stocks to Eyes On: Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB), Dendreon Corporation (NASDAQ:DNDN), TravelCenters of America LLC(NYSEAMEX:TA)

Lakeway, TX -- (SBWIRE) -- 03/18/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB) shares gained 3.37% to $2.76. The company, on Mar. 6, announced consolidated results for the fourth quarter of 2012 and for the year ended December 31, 2012. Fourth quarter 2012 operating expenses were $7.0 million compared to $9.0 million for the fourth quarter of 2011. Operating expenses for the year ended December 31, 2012 were $28.1 million compared to $24.7 million for 2011. The company’s loss from operations for the fourth quarter of 2012 was $7.0 million compared to $9.0 million for the fourth quarter of 2011.

How Should Investors Trade NAVB After The Recent Movement? Find Out Here

Dendreon Corporation (NASDAQ:DNDN) shares is currently trading at $5.41. The company, on Feb. 25, provided a quarterly loss versus a year-ago profit as revenue fell and restructuring costs weighed on the biotechnology company. The fourth-quarter loss was $38.7 million, or 26 cents per share, compared with a profit of $38.1 million, or 26 cents per share. Quarterly revenue fell to $85.5 million from $202.1 million a year ago.

Additionally, the company announced that management will present at the 25th Annual ROTH Conference in Laguna Niguel, California, on March 18, 2013, at 11:00 a.m. PT.

Is DNDN Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

TravelCenters of America LLC(NYSEAMEX:TA) shares jumped 13.08% to $8.56 in the early hour after the company today announced financial results for the fourth quarter and year ended December 31, 2012. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.03. The company had revenue of $1.93 billion for the quarter, compared to the consensus estimate of $1.93 billion. During the same quarter in the previous year, the company posted ($0.09) earnings per share. The company’s revenue for the quarter was up .0% on a year-over-year basis.

Is TA a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.